Universität zu Köln

Waltar, Till and Marnitz, Simone (2020). Clinical Implications of the PORTEC-3 Trial for the Treatment of High-Risk Endometrial Cancer. Strahlenther. Onkol., 196 (4). S. 410 - 414. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1439-099X

Full text not available from this repository.

Item Type:	Journal Article
Creators:	Creators Email ORCID ORCID Put Code Waltar, Till UNSPECIFIED UNSPECIFIED UNSPECIFIED Marnitz, Simone UNSPECIFIED UNSPECIFIED UNSPECIFIED
URN:	urn:nbn:de:hbz:38-344552
DOI:	10.1007/s00066-020-01592-1
Journal or Publication Title:	Strahlenther. Onkol.
Volume:	196
Number:	4
Page Range:	S. 410 - 414
Date:	2020
Publisher:	SPRINGER HEIDELBERG
Place of Publication:	HEIDELBERG
ISSN:	1439-099X
Language:	German
Faculty:	Unspecified
Divisions:	Unspecified
Subjects:	no entry
Uncontrolled Keywords:	Keywords Language PHASE-III TRIAL; ADJUVANT CHEMORADIOTHERAPY; OPEN-LABEL; RADIOTHERAPY; CHEMOTHERAPY; INTERMEDIATE; MULTICENTER; CARCINOMA; RADIATION; WOMEN Multiple languages Oncology; Radiology, Nuclear Medicine & Medical Imaging Multiple languages
URI:	http://kups.ub.uni-koeln.de/id/eprint/34455